Key points from article :
Michigan State University has created a molecular diagnostic system.
Point-of-care diagnostic test “In-Dx” produces results within two hours.
Can use blood, urine, spit, wound, stool or cerebral spine fluid samples.
Currently in a clinical trial – preliminary results already look promising.
Knowing specific bacteria means a much more targeted treatment (e.g. antibiotic) could be given right away.
